NewsPronto

 
Men's Weekly

.

EQS Asia Business News

An international medical journal published results of phase II clinical trial of Shineway's Sai Luo Tong, revealing that it may be safe and effective for treating mild to moderate vascular dementia

  • Written by EQS Asia Business News

EQS-News / 31/05/2018 / 12:08 UTC+8

An international medical journal published results of phase II clinical trial of Shineway's Sai Luo Tong, revealing that it may be safe and effective for treating mild to moderate vascular dementia

 

Recently, "Alzheimer's & Dementia: Translational Research & Clinical Interventions", an international...